Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Low molecular weight heparins and their use in obstetrics and gynecology
Moshe D. Fejgin
, David L. Lourwood
University of Illinois at Chicago
Research output
:
Contribution to journal
›
Article
›
peer-review
71
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Low molecular weight heparins and their use in obstetrics and gynecology'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anticoagulant Effect
14%
Bleeding Complications
14%
Bleeding Risk
14%
Clinical Application
14%
Clinical Experience
14%
Daily Dose
14%
Deep Vein Thrombosis
14%
Enhanced Bioavailability
14%
Gynecologic Surgery
14%
Hip Surgery
14%
Lovenox
14%
Low Molecular Weight Heparin
100%
Mutagenic Effects
14%
Obstetrics and Gynaecology
100%
Paris France
14%
Placenta
14%
Platelet Factor 4
14%
Poulenc
14%
Prolonged Half-life
14%
Rhone
14%
Standard Heparin
14%
Subcutaneous Treatment
14%
Teratogenic Effects
14%
Thrombocytopenia
14%
Thromboembolic Complications
14%
Thromboprophylaxis
14%
Treatment during Pregnancy
14%
Trimester
14%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
14%
Bioavailability
14%
Bleeding
14%
Deep Vein Thrombosis
14%
Enoxaparin
14%
Heparin
14%
Low Molecular Weight Heparin
100%
Prothrombin
14%
Teratogenesis
14%
Thrombocyte Factor 4
14%
Thrombocytopenia
14%
Thromboembolism
14%